SERENADE: the Study Evaluating Rimonabant Efficacy in Drug-naive Diabetic Patients: effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabete (Q36945310)
scientific article published on 04 August 2008
Language:
(P31) (Q13442814)
(P50) (Q60996888)
(P304) 2169-2176
(P407) (Q1860)
(P433) 11
(P478) 31
(P577) Monday, August 4, 2008
(P1433) (Q5270111)
(P1476) "SERENADE: the Study Evaluating Rimonabant Efficacy in Drug-naive Diabetic Patients: effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabete" (language: en)
(P2093) Priscilla Hollander
Soazig Chevalier
Ali Iranmanesh
SERENADE Study Group
(P2860) (Q28253541)
(Q34648377)
(Q36773310)
(Q37151277)
(Q29620534)
(Q34251047)
(Q28283398)
(Q24523292)
(Q38333962)
(Q35833952)
(Q35789756)
(Q31140518)
(Q28575514)
(Q39474763)
(Q29618673)
(Q26776977)
(Q42486321)
(Q46828447)
(Q51478431)
(Q46595047)
(Q47386035)
(Q43626381)
(Q73947393)
(Q60209721)
other details
description scientific article published on 04 August 2008

External Links